Chronic kidney disease and inflammation in pediatric patients: From bench to playground

Pediatric Nephrology

Volumn 20, Issue 6, 2005, Pages 714-720

  Pecoits Filho, Roberto ^a,b   Sylvestre, Lucimary C ^b   Stenvinkel, Peter ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b PONTIFICAL CATHOLIC UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

Cardiovascular disease; Children; Chronic kidney disease; Dialysis; Inflammation

Indexed keywords

CYTOKINE;

ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHILD; CHRONIC INFLAMMATION; CHRONIC KIDNEY DISEASE; DIETARY INTAKE; HEART FAILURE; HEMODIALYSIS; HUMAN; IMMUNE SYSTEM; KIDNEY CLEARANCE; KIDNEY FAILURE; MALNUTRITION; MORBIDITY; MORTALITY; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PREVALENCE; PRIMARY PREVENTION; PRIORITY JOURNAL; REVIEW; RISK FACTOR; UREMIA;

AGING; ANIMALS; CARDIOVASCULAR DISEASES; CHILD; CHRONIC DISEASE; HUMANS; INFLAMMATION; KIDNEY DISEASES;

EID: 18644377770     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-005-1891-z     Document Type: Review

References (71)

1. Tracey KJ (2002) The inflammatory reflex. Nature 420:853-859
2. Oberg BP, McMenamin E, Lucas FL, McMonagle E, Morrow J, Ikizler TA, Himmelfarb J (2004) Increased prevalence of oxidant stress and inflammation in patients with moderate to severe chronic kidney disease. Kidney Int 65:1009-1016
3. Stenvinkel P, Pecoits-Filho R, Lindholm B (2003) Coronary artery disease in end-stage renal disease: No longer a simple plumbing problem. J Am Soc Nephrol 14:1927-1939
4. Pecoits-Filho R, Lindholm B, Stenvinkel P (2002) The malnutrition, inflammation, and atherosclerosis (MIA) syndrome - the heart of the matter. Nephrol Dial Transplant 17 [Suppl 11]:28-31
5. Descamps-Latscha B, Jungers P, Witko-Sarsat V (2002) Immune system dysregulation in uremia: Role of oxidative stress. Blood Purif 20:481-484
6. Girndt M, Sester M, Sester U, Kaul H, Kohler H (2001) Molecular aspects of T- and B-cell function in uremia. Kidney Int [Suppl] 78:S206-211
7. Jaber BL, Cendoroglo M, Balakrishnan VS, Perianayagam MC, King AJ, Pereira BJ (2001) Apoptosis of leukocytes: Basic concepts and implications in uremia. Kidney Int [Suppl] 78:S197-205
8. Stenvinkel P, Heimbürger O, Paultre F, Diczfalusy U, Wang T, Berglund L, Jogestrand T (1999) Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure. Kidney Int 55:1899-1911
9. Pecoits-Filho R, Lindholm B, Stenvinkel P (2003) End-stage renal disease: A state of chronic inflammation and hyperleptinemia. Eur J Clin Invest 33:527-528
10. Qureshi AR, Alvestrand A, Divino-Filho JC, Gutierrez A, Heimbürger O, Lindholm B, Bergstrom J (2002) Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients. J Am Soc Nephrol 13 [Suppl 1]:S28-36
11. Libetta C, De Nicola L, Rampino T, De Simone W, Memoli B (1996) Inflammatory effects of peritoneal dialysis: Evidence of systemic monocyte activation. Kidney Int 49:506-511
12. Pecoits-Filho R, Barany P, Lindholm B, Heimburger O, Stenvinkel P (2002) Interleukin-6 is an independent predictor of mortality in patients starting dialysis treatment. Nephrol Dial Transplant 17:1684-1688
13. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, Fadl YY, Fortmann SP, Hong Y, Myers GL, Rifai N, Smith SC Jr, Taubert K, Tracy RP, Vinicor F (2003) Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107:499-511
14. Lambert M, Delvin EE, Paradis G, O'Loughlin J, Hanley JA, Levy E (2004) C-reactive protein and features of the metabolic syndrome in a population-based sample of children and adolescents. Clin Chem 50:1762-1768
15. Ardissino G, Dacco V, Testa S, Bonaudo R, Claris-Appiani A, Taioli E, Marra G, Edefonti A, Sereni F (2003) Epidemiology of chronic renal failure in children: Data from the ItalKid project. Pediatrics 111:e382-387
16. Seikaly MG, Ho PL, Emmett L, Fine RN, Tejani A (2003) Chronic renal insufficiency in children: The 2001 Annual Report of the NAPRTCS. Pediatr Nephrol 18:796-804
17. van der Heijden BJ, van Dijk PC, Verrier-Jones K, Jager KJ, Briggs JD (2004) Renal replacement therapy in children: Data from 12 registries in Europe. Pediatr Nephrol 19:213-221
18. Pereira BJ, Shapiro L, King AJ, Falagas ME, Strom JA, Dinarello CA (1994) Plasma levels of IL-1 beta, TNF alpha and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 45:890-896
19. Descamps-Latscha B, Herbelin A, Nguyen AT, Roux-Lombard P, Zingraff J, Moynot A, Verger C, Dahmane D, de Groote D, Jungers P, et al (1995) Balance between IL-1 beta, TNF-alpha, and their specific inhibitors in chronic renal failure and maintenance dialysis. Relationships with activation markers of T cells, B cells, and monocytes. J Immunol 154:882-892
20. Memoli B, Postiglione L, Cianciaruso B, Bisesti V, Cimmaruta C, Marzano L, Minutolo R, Cuomo V, Guida B, Andreucci M, Rossi G (2000) Role of different dialysis membranes in the release of interleukin-6 soluble receptor in uremic patients. Kidney Int 58:417-424
21. Bemelmans MH, Gouma DJ, Buurman WA (1993) Influence of nephrectomy on tumor necrosis factor clearance in murine model. J Immunol 150:2007-2017
22. Poole S, Bird TA, Selkirk S, Gaines-Das RE, Choudry Y, Stephenson SL, Kenny AJ, Saklatvaa J (1990) Fate of injected interleukin 1 in rats: Sequestration and degradation in the kidney. Cytokine 2:416-422
23. Niebauer J, Volk H-d, Kemp M, Dominguez M, Schumann RR, Rauchhaus M, Poole-Wilson PA, Coats AJS, Anker SD (1999) Endotoxin and immune activation in chronic heart failure: A prospective cohort study. Lancet 353:1838-1842
24. Wang AY, Wang M, Woo J, Law MC, Chow KM, Li PK, Lui SF, Sanderson JE (2002) A novel association between residual renal function and left ventricular hypertrophy in peritoneal dialysis patients. Kidney Int 62:639-647
25. Suliman ME, Heimburger O, Barany P, Anderstam B, Pecoits-Filho R, Rodriguez Ayala E, Qureshi AR, Fehrman-Ekholm I, Lindholm B, Stenvinkel P: Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy. J Am Soc Nephrol 14:1614-1622, 2003
26. Rodriguez-Ayla E, Anderstam B, Suliman M, Seeberger A, Heimbürger O, Lindholm B, Stenvinkel P (in press) Enhanced RAGE-mediated NFκB stimulation in inflamed hemodialysis patients. Atherosclerosis
27. Misselwitz J, Franke S, Kauf E, John U, Stein G (2002) Advanced glycation end products in children with chronic renal failure and type 1 diabetes. Pediatr Nephrol 17:316-321
28. Sebekova K, Podracka L, Heidland A, Schinzel R (2001) Enhanced plasma levels of advanced glycation end products (AGE) and pro-inflammatory cytokines in children/adolescents with chronic renal insufficiency and after renal replacement therapy by dialysis and transplantation - are they inter-related? Clin Nephrol 56:S21-26
29. Axelsson J, Heimbu7die;rger O, Lindholm B, Stenvinkel P (2005) Adipose tissue and its relation to inflammation: The role of adipokines. J Ren Nutr 15:131-136
30. Axelsson J, Rashid Qureshi A, Suliman ME, Honda H, Pecoits-Filho R, Heimburger O, Lindholm B, Cederholm T, Stenvinkel P (2004) Truncal fat mass as a contributor to inflammation in end-stage renal disease. Am J Clin Nutr 80:1222-1229
31. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in owerweight and obese adults. JAMA 282:2131-2135
32. Owen WF, Lowrie EG (1998) C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 54:627-636
33. Wang AY, Woo J, Lam CW, Wang M, Sea MM, Lui SF, Li PK, Sanderson J (2003) Is a single time point C-reactive protein predictive of outcome in peritoneal dialysis patients? J Am Soc Nephrol 14:1871-1879
34. Yeun JY, Kaysen GA (1997) Acute phase proteins and peritoneal dialysate albumin loss are the main determinants of serum albumin and peritoneal dialysis patients. Am J Kidney Dis 30:923-927
35. Haubitz M, Schulze M, Koch KM (1990) Increase of C-reactive protein serum values following haemodialysis. Nephrol Dial Transpl 5:500-503
36. Schindler R, Boenisch O, Fischer C, Frei U (2000) Effect of the hemodialysis membrane on the inflammatory reaction in vivo. Clin Nephrol 53:452-459
37. Tielemans C, Husson C, Schurmans T, Gastaldello K, Madhoun P, Delville JP, Marchant A, Goldman M, Vanherweghem JL (1996) Effects of ultrapure and non-sterile dialysate on the inflammatory response during in vitro hemodialysis. Kidney Int 49:236-243
38. Lonnemann G (2004) When good water goes bad: How it happens, clinical consequences and possible solutions. Blood Purif 22:124-129
39. Hoenich NA (2003) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 348:1491-1494; author reply 1491-1494
40. Goldstein SL, Currier H, Watters L, Hempe JM, Sheth RD, Silverstein D (2003) Acute and chronic inflammation in pediatric patients receiving hemodialysis. J Pediatr 143:653-657
41. Fujimori A, Naito H, Miyazaki T, Azuma M, Hashimoto S, Horikawa S, Tokukoda Y (1996) Elevation of interleukin 6 in the dialysate reflects peritoneal stimuli and deterioration of peritoneal function. Nephron 74:471-472
42. Pecoits-Filho R, Araujo MR, Lindholm B, Stenvinkel P, Abensur H, Romao JE Jr, Marcondes M, De Oliveira AH, Noronha IL (2002) Plasma and dialysate IL-6 and VEGF concentrations are associated with high peritoneal solute transport rate. Nephrol Dial Transplant 17:1480-1486
43. Konings CJ, Kooman JP, Schonck M, Struijk DG, Gladziwa U, Hoorntje SJ, van der Wall Bake AW, van der Sande FM, Leunissen KM (2003) Fluid status in CAPD patients is related to peritoneal transport and residual renal function: Evidence from a longitudinal study. Nephrol Dial Transplant 18:797-803
44. Zeier M, Schwenger V, Deppisch R, Haug U, Weigel K, Bahner U, Wanner C, Schneider H, Henle T, Ritz E (2003) Glucose degradation products in PD fluids: Do they disappear from the peritoneal cavity and enter the systemic circulation? Kidney Int 63:298-305
45. Foley RN, Parfrey PS, Sarnak MJ (1998) Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis 32:S112-119
46. Gruppen MP, Groothoff JW, Prins M, van der Wouw P, Offringa M, Bos WJ, Davin JC, Heymans HS (2003) Cardiac disease in young adult patients with end-stage renal disease since childhood: A Dutch cohort study. Kidney Int 63:1058-1065
47. Sarnak MJ, Levey AS (2000) Cardiovascular disease and chronic renal disease: A new paradigm. Am J Kidney Dis 35:S117-S131
48. Parekh RS, Carroll CE, Wolfe RA, Port FK (2002) Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr 141:191-197
49. Mitsnefes MM (2002) Pediatric end-stage renal disease: Heart as a target. J Pediatr 141:162-164
50. Wissler RW, Strong JP (1998) Risk factors and progression of atherosclerosis in youth. PDAY Research Group (pathological determinants of atherosclerosis in youth). Am J Pathol 153:1023-1033
51. Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA (1998) Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 338:1650-1656
52. Querfeld U (2002) Is atherosclerosis accelerated in young patients with end-stage renal disease? The contribution of paediatric nephrology. Nephrol Dial Transplant 17:719-722
53. Offner G, Latta K, Hoyer PF, Baum HJ, Ehrich JH, Pichlmayr R, Brodehl J (1999) Kidney transplanted children come of age. Kidney Int 55:1509-1517
54. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483
55. Querfeld U, Salusky IB, Nelson P, Foley J, Fine RN (1988) Hyperlipidemia in pediatric patients undergoing peritoneal dialysis. Pediatr Nephrol 2:447-452
56. Silverstein DM, Palmer J, Polinsky MS, Braas C, Conley SB, Baluarte HJ (2000) Risk factors for hyperlipidemia in long-term pediatric renal transplant recipients. Pediatr Nephrol 14:105-110
57. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, Teehan BP, Levey AS (2000)Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 58:353-362
58. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F (2002) Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 106:100-105
59. Bennett-Richards KJ, Kattenhorn M, Donald AE, Oakley GR, Varghese Z, Bruckdorfer KR, Deanfield JE, Rees L (2002) Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure. Kidney Int 62:1372-1378
60. Querfeld U (2004) The clinical significance of vascular calcification in young patients with end-stage renal disease. Pediatr Nephrol 19:478-484
61. Sheth RD, Perez MD, Goldstein SL (2003) Cardiovascular calcifications in pediatric patients receiving maintenance dialysis. Pediatr Nephrol 18:810-813
62. Lowrie EG, Lew NL (1990) Death risk in hemodialysis patients: The predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis 15:458-482
63. Besbas N, Ozdemir S, Saatci U, Coskun T, Ozen S, Topaloglu R, Bakkaloglu A, El Nahas AM (1998) Nutritional assessment of children on haemodialysis: Value of IGF-I, TNF-alpha and IL-1beta. Nephrol Dial Transplant 13:1484-1488
64. Ekim M, Ikinciogullari A, Ulukol B, Bakkaloglu SA, Ozkaya N, Kendirli T, Adiyaman P, Babacan E, Ocal G (2003) Evaluation of nutritional status and factors related to malnutrition in children on CAPD. Perit Dial Int 23:557-562
65. Wong CS, Hingorani S, Gillen DL, Sherrard DJ, Watkins SL, Brandt JR, Ball A, Stehman-Breen CO (2002) Hypoalbuminemia and risk of death in pediatric patients with end-stage renal disease. Kidney Int 61:630-637
66. Foster BJ, Leonard MB (2004) Measuring nutritional status in children with chronic kidney disease. Am J Clin Nutr 80:801-814
67. Wong CS, Gipson DS, Gillen DL, Emerson S, Koepsell T, Sherrard DJ, Watkins SL, Stehman-Breen C (2000) Anthropometric measures and risk of death in children with end-stage renal disease. Am J Kidney Dis 36:811-819
68. Koretz RL (1999) Does nutritional intervention in protein-energy malnutrition improve morbidity or mortality? J Ren Nutr 9:119-121
69. Beddhu S, Zeidel S, Stark S, Saul M, Bruns F (1999) Comorbidity influences the impact of albumin (Alb) on dialysis outcomes. J Am Soc Nephrol 10:234A
70. Kaysen GA, Dublin JA, Müller HG, Rosales LM, Levin NW (2000) The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. Kidney Int 58:346-352
71. Misselwitz J, Franke S, Kauf E, John U, Stein G (2002) Advanced glycation end products in children with chronic renal failure and type 1 diabetes. Pediatr Nephrol 17:316-321